Mylan NV
(NASDAQ : MYL)

( )
MYL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-1.03%138.752.8%$305.02m
ZTSZoetis, Inc. Class A
0.23%102.201.9%$195.68m
MYLMylan N.V.
-1.12%19.423.2%$182.88m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-1.20%11.492.0%$176.58m
TXMDTherapeuticsMD, Inc.
-1.20%3.2924.9%$12.62m
PETXAratana Therapeutics, Inc.
-0.62%4.858.5%$10.30m
TAROTaro Pharmaceutical Industries Ltd.
-0.24%100.306.4%$6.43m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
-5.84%37.082.0%$5.42m
ABEOAbeona Therapeutics, Inc.
-1.34%7.347.6%$2.77m
KINKindred Biosciences, Inc.
0.12%8.410.3%$1.60m
LFVNLifeVantage Corporation
-0.35%11.463.3%$1.29m
JAGXJaguar Animal Health, Inc.
-9.91%0.199.8%$0.62m
CPHIChina Pharma Holdings, Inc.
-5.07%0.280.1%$0.09m

Company Profile

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.